Cargando…
Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa
Tuberculosis (TB) remains a leading infectious disease killer globally. Treatment outcomes are especially poor among people with extensively drug-resistant (XDR) TB, until recently defined as rifampicin-resistant (RR) TB with resistance to an aminoglycoside (amikacin) and a fluoroquinolone (ofloxaci...
Autores principales: | Sy, Karla Therese L., Leavitt, Sarah V., de Vos, Margaretha, Dolby, Tania, Bor, Jacob, Horsburgh, C. Robert, Warren, Robin M., Streicher, Elizabeth M., Jenkins, Helen E., Jacobson, Karen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237070/ https://www.ncbi.nlm.nih.gov/pubmed/35760977 http://dx.doi.org/10.1038/s41598-022-14581-4 |
Ejemplares similares
-
Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
por: Leavitt, Sarah V., et al.
Publicado: (2021) -
Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
por: Oostvogels, Selien, et al.
Publicado: (2022) -
Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis
por: McIntosh, Avery I., et al.
Publicado: (2018) -
Health research in the Western Cape province, South Africa: Lessons and challenges
por: London, Leslie, et al.
Publicado: (2014) -
Palliative care made visible: Developing a rural model for the Western Cape Province, South Africa
por: O’Brien, Victoria, et al.
Publicado: (2019)